Bank Julius Baer & Co’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-13,719
Closed -$239K – 590
2023
Q1
$239K Buy
+13,719
New +$195K ﹤0.01% 421
2021
Q4
– Sell
-328,733
Closed -$15.9M – 871
2021
Q3
$15.9M Buy
+328,733
New +$15.2M 0.1% 132
2021
Q1
– Sell
-873
Closed -$47K – 866
2020
Q4
$47K Buy
+873
New +$39.4K ﹤0.01% 690

Other funds holding NEO

Bank Julius Baer & Co's NEO Position: Q2 2023 in Review

Bank Julius Baer & Co sold out of NeoGenomics (NEO) in Q2 2023, closing a stake of 13,719 shares — an estimated $239K sold.

Bank Julius Baer & Co first reported a position in NEO in Q4 2020 and held it in 3 quarters. The position peaked at $15.9M in Q3 2021. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2023.

  • Bank Julius Baer & Co reported no remaining NeoGenomics position as of Q2 2023 after selling out during the quarter.
  • Bank Julius Baer & Co sold 13,719 NeoGenomics shares in Q2 2023, an estimated $239K.
  • Bank Julius Baer & Co first reported a position in NeoGenomics in Q4 2020 and held it in 3 quarters.
  • Bank Julius Baer & Co's NeoGenomics position peaked at $15.9M in Q3 2021.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2023.

Based on Bank Julius Baer & Co's 13F filing for Q2 2023, filed 20 Jul 2023.